The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI.


Journal

Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 14 4 2019
medline: 10 9 2020
entrez: 14 4 2019
Statut: ppublish

Résumé

Pancreatic neuroendocrine tumors (pNETs) are rare neoplasms that secrete peptides and neuro-amines. pNETs can be sporadic or hereditary, syndromic or non-syndromic with different clinical presentations and prognoses. The role of medical imaging includes locating the tumor, assessing its extent, and evaluating the feasibility of curative surgery or cytoreduction. Pancreatic NETs have very distinctive phenotypes on CT, MRI, and PET. PET have been demonstrated to be very sensitive to detect either well-differentiated pNETs using

Identifiants

pubmed: 30980115
doi: 10.1007/s00261-019-01994-5
pii: 10.1007/s00261-019-01994-5
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2474-2493

Auteurs

Laura Rozenblum (L)

Sorbonne Université, Service de Médecine Nucléaire, AP-HP, Hôpital La Pitié-Salpêtrière, 75013, Paris, France.

Fatima-Zohra Mokrane (FZ)

Radiology Department, Toulouse University Hospital, 1 Avenue du Professeur Jean Poulhes, 31059, Toulouse, France.
Department of Radiology, New York Presbyterian Hospital, Columbia University, New York, NY, USA.

Randy Yeh (R)

Memorial Sloan Kettering Cancer Center, Molecular Imaging and Therapy Service, New York, NY, USA.

Mathieu Sinigaglia (M)

Department of Imaging and Nuclear Medicine, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France.

Florent Besson (F)

Paris Sud University, Kremlin Bicêtre Hospital, Paris, France.

Romain-David Seban (RD)

Department of Nuclear Medicine, Institut Curie-René Huguenin, Saint-Cloud, France.

Cecile N Chougnet (CN)

Department of Endocrine Oncology, Hôpital Saint Louis, Paris, France.

Paul Revel-Mouroz (P)

Radiology Department, Toulouse University Hospital, 1 Avenue du Professeur Jean Poulhes, 31059, Toulouse, France.

Binsheng Zhao (B)

Department of Radiology, New York Presbyterian Hospital, Columbia University, New York, NY, USA.

Philippe Otal (P)

Radiology Department, Toulouse University Hospital, 1 Avenue du Professeur Jean Poulhes, 31059, Toulouse, France.

Lawrence H Schwartz (LH)

Department of Radiology, New York Presbyterian Hospital, Columbia University, New York, NY, USA.

Laurent Dercle (L)

Department of Radiology, New York Presbyterian Hospital, Columbia University, New York, NY, USA. ld2752@cumc.columbia.edu.
UMR 1015, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, 94805, France. ld2752@cumc.columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH